会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明申请
    • SYSTEM AND METHOD FOR ADJUSTING AUTOMATIC PULSE PARAMETERS TO SELECTIVELY ACTIVATE NERVE FIBERS
    • 用于调整自动脉冲参数以选择性激活神经纤维的系统和方法
    • US20100125314A1
    • 2010-05-20
    • US12606050
    • 2009-10-26
    • Kerry BradleyBradley HersheyDongchul Lee
    • Kerry BradleyBradley HersheyDongchul Lee
    • A61N1/08
    • A61N1/36192A61N1/36071A61N1/37247
    • A method of stimulating nerve tissue, a tissue stimulation system, and an external control device are provided. The method, system, and control device causes an electrical stimulus to be applied to at least one electrode adjacent the nerve tissue of a patient. The applied electrical stimulus comprises a plurality of pulses defined by a pulse width value and an amplitude value. The pulse amplitude value is increased (e.g., manually), and the pulse width value is automatically decreased in response to increasing the pulse amplitude value in a manner that increases the intensity of the applied electrical stimulus. Alternatively, the pulse width value may be decreased (e.g., manually), and the pulse amplitude value automatically increased in response to decreasing the pulse width value in a manner that increases the intensity of the applied electrical stimulus.
    • 提供刺激神经组织,组织刺激系统和外部控制装置的方法。 该方法,系统和控制装置使得电刺激被施加到邻近患者神经组织的至少一个电极。 所施加的电刺激包括由脉冲宽度值和振幅值定义的多个脉冲。 脉冲幅度值增加(例如,手动),并且响应于以增加所施加的电刺激的强度的方式增加脉冲幅值来自动减小脉冲宽度值。 或者,可以减小脉冲宽度值(例如,手动地),并且响应于以增加所施加的电刺激的强度的方式减小脉冲宽度值,脉冲振幅值自动增加。
    • 43. 发明申请
    • STIMULATION PROGRAMMER WITH CLINICALLY-ADAPTIVE MODALITY
    • 具有临床自适应模式的刺激编程器
    • US20080114416A1
    • 2008-05-15
    • US11559377
    • 2006-11-13
    • Margaret E. TheriotKerry BradleyHolly A. Segel
    • Margaret E. TheriotKerry BradleyHolly A. Segel
    • A61N1/08
    • A61N1/37264A61N1/3605A61N1/36071A61N1/37247
    • Tissue stimulation systems generally include a pulse generating device for generating electrical stimulation pulses, at least one implanted electrode for delivering the electrical stimulation pulses generated by the pulse generating device, and a programmer capable of communicating with the pulse generating device. In tissue stimulation systems, a clinically-adaptive stimulation programmer may be utilized, wherein a user communicates to the programmer a purpose of a programming session and a person who is to control the programming session. The clinically-adaptive stimulation programmer may be capable of determining a series of steps required to implement the programming session based on the selected purpose and the selected person. The clinically-adaptive programmer may implement the determined series of steps and communicate with the selected person during the programming session. Also provided are programming methods employing the clinically-adaptive programmer.
    • 组织刺激系统通常包括用于产生电刺激脉冲的脉冲产生装置,用于传递由脉冲发生装置产生的电刺激脉冲的至少一个注入电极以及能够与脉冲发生装置通信的编程器。 在组织刺激系统中,可以利用临床适应性刺激程序员,其中用户向程序员传达编程会话的目的和要控制编程会话的人。 临床适应性刺激程序员可能能够基于所选择的目的和所选择的人来确定实现编程会话所需的一系列步骤。 临床适应性程序员可以在编程会话期间实施所确定的一系列步骤并与所选择的人进行通信。 还提供了采用临床适应性编程器的编程方法。
    • 44. 发明授权
    • Method for increasing the therapeutic ratio/usage range in a neurostimulator
    • US07127296B2
    • 2006-10-24
    • US10285817
    • 2002-11-01
    • Kerry Bradley
    • Kerry Bradley
    • A61N1/20
    • A61N1/36071
    • A system and method for patient control of the stimulation parameters of a Spinal Cord Stimulation (SCS) system, or other neurostimulation system, provides an increased Therapeutic Ratio (TR). Measurements of the just-perceptible stimulation level and the maximum-comfortable stimulation level are made for at least two values of pulse duration and two values of pulse amplitude. A Therapeutic Ratio is determined for stimulation level control strategies based on fixed pulse duration and variable pulse amplitude, and alternatively for fixed pulse amplitude and variable pulse duration. The control strategy providing the greatest therapeutic ratio is then selected for use by the patient. In an alternative embodiment, the pulse durations at the just-perceptible and maximum-comfortable stimulation levels are measured, and the pulse amplitudes at the just-perceptible and maximum-comfortable stimulation levels are determined using a curve-fitting process. Similarly, the pulse amplitudes may first be measured and the pulse widths determined using a curve-fitting process.
    • 46. 发明申请
    • Apparatus and method for determining the relative position and orientation of neurostimulation leads
    • US20060122654A1
    • 2006-06-08
    • US11343007
    • 2006-01-30
    • Kerry BradleyJames Thacker
    • Kerry BradleyJames Thacker
    • A61N1/37
    • A61N1/08A61B5/053A61N1/0551
    • Interelectrode impedance or electric field potential measurements are used to determine the relative orientation of one lead to other leads in the spinal column or other body/tissue location. Interelectrode impedance is determined by measuring impedance vectors. The value of the impedance vector is due primarily to the electrode-electrolyte interface, and the bulk impedance between the electrodes. The bulk impedance between the electrodes is, in turn, made up of (1) the impedance of the tissue adjacent to the electrodes, and (2) the impedance of the tissue between the electrodes. In one embodiment, the present invention makes both monopolar and bipolar impedance measurements, and then corrects the bipolar impedance measurements using the monopolar measurements to eliminate the effect of the impedance of the tissue adjacent the electrodes. The orientation and position of the leads may be inferred from the relative minima of the corrected bipolar impedance values. These corrected impedance values may also be mapped and stored to facilitate a comparison with subsequent corrected impedance measurement values. Such comparison allows a determination to be made as to whether the lead position and/or orientation has changed appreciably over time. In another embodiment, one or more electrodes are stimulated and the resulting electric field potential on the non-stimulated electrodes is measured. Such field potential measurements provide an indication of the relative orientation of the electrodes. Once known, the relative orientation may be used to track lead migration, to setup stimulation configurations and parameters for nominal stimulation and/or navigation. Also, such measurements allow automatic adjustment of stimulation energy to a previously-defined optimal potential field in the case of lead migration or postural changes.
    • 47. 发明授权
    • Method and apparatus for monitoring myocardial conduction velocity for diagnostics of therapy optimization
    • 监测心肌传导速度的方法和装置,用于诊断治疗优化
    • US06931281B2
    • 2005-08-16
    • US10121523
    • 2002-04-12
    • Kerry BradleyJeffery D. Snell
    • Kerry BradleyJeffery D. Snell
    • A61N1/37A61N1/362
    • A61N1/371
    • A cardiac stimulation device and method to measure a myocardial conduction time and to store its long-term running average. A multipolar lead is used to deliver a stimulation pulse from a tip electrode and detect the evoked response after it has propagated to a ring electrode. The time between the stimulation pulse and a detected feature of the evoked response is determined as the myocardial conduction time. A long-term average myocardial conduction time is calculated by averaging on the order of five hundred stimulated cardiac cycles, and a running average is stored in memory. Shifts in the myocardial conduction time may be used for monitoring disease progression or the long-term response to a treatment.
    • 心脏刺激装置和测量心肌传导时间并存储其长期运行平均值的方法。 多极引线用于从尖端电极传递刺激脉冲,并在其传播到环形电极之后检测诱发反应。 刺激脉冲与诱发反应的检测特征之间的时间被确定为心肌传导时间。 长期平均心肌传导时间是通过对五百个刺激心脏周期的量级进行平均来计算的,运行平均值存储在记忆中。 心肌传导时间的变化可用于监测疾病进展或对治疗的长期反应。
    • 48. 发明授权
    • Detection of orthostatic hypotension using positional data and cross-check data
    • 使用位置数据和交叉检查数据检测直立性低血压
    • US06738666B1
    • 2004-05-18
    • US10002615
    • 2001-11-01
    • Euljoon ParkKerry Bradley
    • Euljoon ParkKerry Bradley
    • A61N1365
    • A61N1/36542
    • An implantable cardiac stimulation device is programmed to administer pacing therapy in response to a postural change in a patient's position and a confirmation of that postural change using a cross-check parameter. The stimulation device is equipped with a position sensor to sense a position parameter indicative of when a patient changes from a horizontal position to an upright position. The stimulation device further monitors a cross-check parameter that is affected or modulated by position changes. When the position sensor indicates a postural change and the cross-check parameter confirms this change as being sufficient to induce orthostatic hypotension, the device administers cardiac pacing therapy to the patient.
    • 可植入心脏刺激装置被编程为响应于患者位置的姿势变化来管理起搏治疗,并且使用交叉检查参数来确认该姿势改变。 刺激装置配备有位置传感器,用于感测指示患者什么时候从水平位置变化到直立位置的位置参数。 刺激装置还监视受位置变化影响或调制的交叉检查参数。 当位置传感器指示姿势变化并且交叉检查参数证实该变化足以引起直立性低血压时,该装置对患者进行心脏起搏治疗。